Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

More than 50% of human cancers contain p53 gene mutations and as a result accumulate altered forms of the full-length p53 protein. Although certain tumor types expressing mutant p53 protein have a poor prognostic process, the precise role of mutant p53 protein in highly malignant tumor cells is not...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ohiro, Yoichi, Usheva, Anny, Kobayashi, Shinichiro, Duffy, Shannon L., Nantz, Regan, Gius, David, Horikoshi, Nobuo
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2003
Assuntos:
Cell Growth and Development
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC140653/
https://ncbi.nlm.nih.gov/pubmed/12482984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/MCB.23.1.322-334.2003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares